JP2018150331A5 - - Google Patents

Download PDF

Info

Publication number
JP2018150331A5
JP2018150331A5 JP2018088646A JP2018088646A JP2018150331A5 JP 2018150331 A5 JP2018150331 A5 JP 2018150331A5 JP 2018088646 A JP2018088646 A JP 2018088646A JP 2018088646 A JP2018088646 A JP 2018088646A JP 2018150331 A5 JP2018150331 A5 JP 2018150331A5
Authority
JP
Japan
Prior art keywords
disease
compound according
pharmaceutically acceptable
acceptable salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018088646A
Other languages
English (en)
Japanese (ja)
Other versions
JP6654659B2 (ja
JP2018150331A (ja
Filing date
Publication date
Priority claimed from US13/843,261 external-priority patent/US8957066B2/en
Application filed filed Critical
Publication of JP2018150331A publication Critical patent/JP2018150331A/ja
Publication of JP2018150331A5 publication Critical patent/JP2018150331A5/ja
Application granted granted Critical
Publication of JP6654659B2 publication Critical patent/JP6654659B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018088646A 2013-03-15 2018-05-02 ヒストン脱アセチル化酵素阻害剤 Expired - Fee Related JP6654659B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/843,261 US8957066B2 (en) 2011-02-28 2013-03-15 Histone deacetylase inhibitors
US13/843,261 2013-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016502408A Division JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019188049A Division JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Publications (3)

Publication Number Publication Date
JP2018150331A JP2018150331A (ja) 2018-09-27
JP2018150331A5 true JP2018150331A5 (enExample) 2018-12-13
JP6654659B2 JP6654659B2 (ja) 2020-02-26

Family

ID=49622075

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016502408A Expired - Fee Related JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤
JP2018088646A Expired - Fee Related JP6654659B2 (ja) 2013-03-15 2018-05-02 ヒストン脱アセチル化酵素阻害剤
JP2019188049A Pending JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016502408A Expired - Fee Related JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019188049A Pending JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Country Status (15)

Country Link
US (6) US8957066B2 (enExample)
EP (2) EP3695836A1 (enExample)
JP (3) JP6336562B2 (enExample)
KR (1) KR20150132342A (enExample)
CN (2) CN105120860B (enExample)
AU (1) AU2014239677B2 (enExample)
BR (1) BR112015023434A8 (enExample)
CA (2) CA2903486C (enExample)
DK (1) DK2968251T3 (enExample)
ES (1) ES2780693T3 (enExample)
IL (3) IL240938B (enExample)
MX (2) MX375260B (enExample)
PT (1) PT2968251T (enExample)
RU (1) RU2673819C2 (enExample)
WO (1) WO2014152444A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028192A1 (en) 2008-09-03 2010-03-11 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2680694B1 (en) * 2011-02-28 2019-01-02 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2712655B1 (en) 2011-04-28 2019-12-18 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
CN105121415B (zh) 2013-03-15 2018-10-12 生物马林药物股份有限公司 Hdac抑制剂
WO2015069693A1 (en) * 2013-11-05 2015-05-14 Dana-Farber Cancer Institute, Inc. Inhibitors of histone deacetylase
JP2018525342A (ja) * 2015-07-02 2018-09-06 バイオマリン ファーマシューティカル インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US20180305318A1 (en) 2015-10-30 2018-10-25 Bioventures, Llc Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
TW201829381A (zh) * 2016-12-22 2018-08-16 美商拜奧馬林製藥公司 組蛋白脫乙醯基酶抑制劑
EA039417B1 (ru) * 2017-08-07 2022-01-25 Родин Терапеутикс, Инк. Бициклические ингибиторы гистондеацетилазы
US11458122B2 (en) * 2017-08-09 2022-10-04 Children's Hospital Medical Center Methods for treating diseases and nerve injuries
WO2019140322A1 (en) 2018-01-12 2019-07-18 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
AU2019316858B2 (en) * 2018-08-06 2024-03-28 Moexa Pharmaceuticals Limited Smad3 inhibitors
GB201901559D0 (en) 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
WO2021060567A1 (en) 2019-09-27 2021-04-01 Takeda Pharmaceutical Company Limited 2-isoindol-1,3,4-oxadiazole derivatives useful as hdac6 inhibitors

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174958A (en) * 1978-01-09 1979-11-20 Shell Oil Company Anilide derivative herbicides
US4855442A (en) 1988-04-13 1989-08-08 Monsanto Company Substituted 3-hydroxy pyrazoles
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JPH11269140A (ja) 1998-03-23 1999-10-05 Mitsui Chem Inc 分化誘導剤
JPH11269146A (ja) 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
US6331545B1 (en) 1998-12-18 2001-12-18 Soo S. Ko Heterocycyclic piperidines as modulators of chemokine receptor activity
JP2000256194A (ja) 1999-01-06 2000-09-19 Mitsui Chemicals Inc 核内レセプタ作動薬およびその効果増強剤
EP1182192A4 (en) 1999-04-09 2002-06-05 Mochida Pharm Co Ltd 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT
JP2001072592A (ja) * 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
CA2391952C (en) 1999-11-23 2012-01-31 Methylgene Inc. Inhibitors of histone deacetylase
AU2001280187A1 (en) 2000-08-28 2002-03-13 Toray Industries, Inc. Cyclic amine derivatives
GB0021419D0 (en) * 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
EP1322637A2 (en) * 2000-09-29 2003-07-02 Millennium Pharmaceuticals, Inc. Quaternary amidino based inhibitors of factor xa
WO2002090534A1 (en) 2001-05-02 2002-11-14 The Regents Of The University Of California Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
US20040142859A1 (en) 2002-05-02 2004-07-22 Steffan Joan S. Method for treating neurodegenerative, psychiatric, and other disorders with deacetylase inhibitors
US6784173B2 (en) 2001-06-15 2004-08-31 Hoffmann-La Roche Inc. Aromatic dicarboxylic acid derivatives
AR034897A1 (es) 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
CN1290715C (zh) 2001-09-27 2006-12-20 株式会社Api 用于热记录材料的显影剂和热记录材料
JP2003137866A (ja) 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体
JP4725946B2 (ja) 2002-03-13 2011-07-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの新規な阻害剤としてのスルホニル誘導体
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
US20040072770A1 (en) 2002-07-03 2004-04-15 Besterman Jeffrey M. Methods for specifically inhibiting histone deacetylase-7 and 8
JP2004035485A (ja) 2002-07-04 2004-02-05 Mitsui Chemicals Inc テロメラーゼ阻害剤
US20050215601A1 (en) 2002-09-25 2005-09-29 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
JP2006503082A (ja) 2002-10-17 2006-01-26 メシルジーン、インコーポレイテッド ヒストンデアセチラーゼの阻害剤
EP1562931A2 (en) 2002-10-25 2005-08-17 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
US6852748B1 (en) 2002-10-30 2005-02-08 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
TW200426138A (en) 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
WO2004058234A2 (en) 2002-12-27 2004-07-15 Schering Aktiengesellschaft Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
US7208491B2 (en) 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
MXPA05008309A (es) 2003-02-10 2005-09-20 Amgen Inc Ligandos de receptor vaniloide y su uso en tratamientos.
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
US7030112B2 (en) 2003-03-25 2006-04-18 Bristol-Myers Squibb Company Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
TW200424187A (en) 2003-04-04 2004-11-16 Hoffmann La Roche New oxime derivatives and their use as pharmaceutically active agents
GB0315203D0 (en) 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
ATE469878T1 (de) 2003-07-24 2010-06-15 Leo Pharma As Aminobenzophenonverbindungen
US20070276011A1 (en) * 2003-09-11 2007-11-29 Susumu Muto Plasminogen Activator Inhibitor-1 Inhibitor
AU2004276337B2 (en) 2003-09-24 2009-11-12 Methylgene Inc. Inhibitors of histone deacetylase
WO2005035551A2 (en) 2003-10-08 2005-04-21 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
WO2005055928A2 (en) 2003-12-02 2005-06-23 The Ohio State University Research Foundation Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
EP1541549A1 (en) 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
PL1702917T3 (pl) * 2003-12-25 2018-02-28 Nippon Shinyaku Co., Ltd. Pochodna amidowa i lek
DK1725528T3 (da) 2004-03-11 2013-09-02 4Sc Ag Sulfonylpyrroler som hdac-inhibitorer
PL2156824T3 (pl) 2004-03-25 2013-03-29 Astellas Pharma Inc Kompozycja solifenacyny lub jej soli do zastosowania w formulacji stałej
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
JP5319113B2 (ja) * 2004-03-26 2013-10-16 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
EP1753740A2 (en) 2004-05-21 2007-02-21 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
JP2008501771A (ja) 2004-06-10 2008-01-24 キャンサー・リサーチ・テクノロジー・リミテッド ヒストン脱アセチル化酵素阻害剤
AU2005261501A1 (en) 2004-07-12 2006-01-19 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Amide derivatives as inhibitors of histone deacetylase
CN1993124A (zh) 2004-07-22 2007-07-04 默克公司 取代吡唑、含有这种化合物的组合物及其应用
EP1797072A4 (en) 2004-09-17 2009-09-09 Exelixis Inc PYRAZOLKINASE MODULATORS AND USE METHOD
AU2005314601A1 (en) 2004-10-15 2006-06-15 Bayer Pharmaceuticals Corporation Indane amides with antiproliferative activity
CN100349070C (zh) 2004-11-25 2007-11-14 同济大学 一种偶氮/酞菁复合单层有机光电导体及其制备方法
AU2005316668B2 (en) 2004-12-13 2012-09-06 Millennium Pharmaceuticals, Inc. Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
EP1824831A2 (en) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008526721A (ja) 2004-12-30 2008-07-24 アステックス、セラピューティックス、リミテッド Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するチアゾールおよびイソチアゾール誘導体
WO2006097474A1 (en) 2005-03-15 2006-09-21 Nycomed Gmbh N-sulphonylpyrroles and their use as histone deacetylase inhibitors
US20060223807A1 (en) 2005-03-29 2006-10-05 University Of Massachusetts Medical School, A Massachusetts Corporation Therapeutic methods for type I diabetes
WO2006102760A1 (en) 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
JP5054671B2 (ja) 2005-04-07 2012-10-24 フォーエスシー アクチエンゲゼルシャフト ヒストンデアセチラーゼインヒビターとしてのスルホニルピロール
EP1874295A4 (en) 2005-04-20 2009-08-12 Merck & Co Inc benzothiophene
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP4528918B2 (ja) 2005-06-21 2010-08-25 学校法人 関西大学 カルボキサミド誘導体
US8158825B2 (en) 2005-06-24 2012-04-17 Merck Sharp & Dohme Corp. Modified malonate derivatives
US7732475B2 (en) 2005-07-14 2010-06-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
AU2006284403A1 (en) 2005-08-26 2007-03-01 Methylgene Inc. Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
BRPI0615781A2 (pt) 2005-09-01 2009-06-16 Array Biopharma Inc compostos inibidores de raf e métodos de uso destes
KR101314158B1 (ko) 2005-09-21 2013-10-04 4에스체 악티엔게젤샤프트 히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염
DK1928872T3 (da) 2005-09-21 2012-05-07 4Sc Ag Hidtil ukendte sulfonylpyrroler som inhibitorer af hdac
US7754773B2 (en) 2005-10-06 2010-07-13 University Of Massachusetts Composition and synthesis of new reagents for inhibition of HIV replication
GB0521244D0 (en) * 2005-10-19 2005-11-30 Astrazeneca Ab Benzamide compounds
CA2626898A1 (en) 2005-11-03 2007-05-18 Christopher Hamblett Substituted nicotinamide compounds
US20070219244A1 (en) 2005-11-11 2007-09-20 The Scripps Research Institute Histone deacetylase inhibitors as therapeutics for neurological diseases
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
US20090062297A1 (en) 2006-01-12 2009-03-05 Heidebrecht Richard W Hydroxyalkylarylamide Derivatives
US20090012075A1 (en) 2006-01-12 2009-01-08 Miller Thomas A Fluorinated Arylamide Derivatives
EP1976835A2 (en) 2006-01-13 2008-10-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
CN101370790B (zh) 2006-01-19 2015-10-21 詹森药业有限公司 作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物
JP5137848B2 (ja) 2006-01-19 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
ES2376121T3 (es) 2006-01-19 2012-03-09 Janssen Pharmaceutica, N.V. Derivados de heterociclilalquilo como nuevos inhibidores de histona deacetilasa.
WO2007082878A1 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Aminophenyl derivatives as novel inhibitors of histone deacetylase
CN101370803B (zh) 2006-01-19 2012-12-12 詹森药业有限公司 作为组蛋白脱乙酰酶抑制剂的取代的吲哚基-烷基-氨基衍生物
JP2009528354A (ja) 2006-02-28 2009-08-06 メルク エンド カムパニー インコーポレーテッド ヒストン脱アセチル化酵素のインヒビター
GB0606876D0 (en) 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
CA2648804C (en) 2006-04-07 2014-05-27 Methylgene Inc. Benzamide derivatives as inhibitors of histone deacetylase
AU2007254359A1 (en) 2006-05-18 2007-11-29 Merck Sharp & Dohme Corp. Aryl-fused spirocyclic compounds
GB0614070D0 (en) 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
CA2657288A1 (en) 2006-07-20 2008-01-24 Merck & Co., Inc. Phosphorus derivatives as histone deacetylase inhibitors
US8653278B2 (en) 2006-08-03 2014-02-18 Georgetown University Isoform selective HDAC inhibitors
CA2663147A1 (en) 2006-09-11 2008-03-20 Curis, Inc. Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
KR20090077914A (ko) 2006-09-11 2009-07-16 쿠리스 인코퍼레이션 항증식제로서의 다작용성 소분자
ME01514B (me) * 2006-09-15 2014-04-20 Janssen Pharmaceutica Nv Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma
EP1973872A4 (en) 2006-12-19 2012-05-09 Methylgene Inc HISTONDEACETYLASE HEMMER AND PROPHARMAKA THEREOF
WO2008078762A1 (ja) 2006-12-26 2008-07-03 Santen Pharmaceutical Co., Ltd. ウレア構造を有する新規ｎ－(２－アミノフェニル)ベンズアミド誘導体
WO2008084218A1 (en) 2007-01-12 2008-07-17 Boehringer Ingelheim International Gmbh Benzazole derivatives for the treatment of inflammations
TW200911757A (en) 2007-01-18 2009-03-16 Takeda San Diego Inc Crystalline forms of histone deacetylase inhibitors
US8030344B2 (en) 2007-03-13 2011-10-04 Methylgene Inc. Inhibitors of histone deacetylase
GEP20135925B (en) 2007-03-14 2013-10-10 Exelixis Patent Co Llc Inhibitors of hedgehog pathway
CN103087043A (zh) 2007-03-16 2013-05-08 中国人民解放军军事医学科学院放射与辐射医学研究所 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
KR20090128513A (ko) 2007-03-28 2009-12-15 산텐 세이야꾸 가부시키가이샤 우레아 구조를 갖는 신규 피리딘카르복실산(2-아미노페닐)아미드 유도체
KR20090125209A (ko) 2007-03-28 2009-12-03 산텐 세이야꾸 가부시키가이샤 히스톤 탈아세틸화 효소 저해 작용을 갖는 화합물을 유효 성분으로서 함유하는 안압 하강제
JP5746860B2 (ja) 2007-04-09 2015-07-08 メチルジーン インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP2010531875A (ja) 2007-06-26 2010-09-30 ギリード・サイエンシズ・インコーポレーテッド イミダゾピリジニルチアゾリルヒストンデアセチラーゼ阻害剤
AU2008269154B2 (en) 2007-06-27 2014-06-12 Merck Sharp & Dohme Llc 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
WO2009004427A2 (en) 2007-06-29 2009-01-08 Pfizer Inc. Benzimidazole derivatives
US20100267779A1 (en) 2007-07-23 2010-10-21 Syndax Pharmaceuticals, Inc. Novel Compounds and Methods of Using Them
JP2010535766A (ja) 2007-08-09 2010-11-25 メルク・シャープ・エンド・ドーム・コーポレイション ヒストン脱アセチル化酵素阻害剤としてのケイ素誘導体
WO2009024825A1 (en) 2007-08-21 2009-02-26 Astrazeneca Ab 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
US20120004222A1 (en) 2007-08-21 2012-01-05 Zhicai Wu Cb2 receptor ligands for the treatment of pain
TW200918521A (en) 2007-08-31 2009-05-01 Astrazeneca Ab Heterocyclic amides and methods of use thereof
WO2009036057A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Antiproliferative agents containing a zinc binding moiety
TW200924777A (en) 2007-09-14 2009-06-16 Methylgene Inc Combination therapy
CA2700058A1 (en) 2007-09-19 2009-03-26 4Sc Ag Novel tetrahydrofusedpyridines
CN101854804B (zh) 2007-10-01 2014-07-23 利克斯特生物技术公司 Hdac抑制剂
RU2453536C2 (ru) * 2007-10-22 2012-06-20 Оркид Рисерч Лабораториз Лимитед Ингибиторы гистондезацетилазы
EP2060565A1 (en) 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
WO2009079391A1 (en) 2007-12-14 2009-06-25 Gilead Colorado, Inc. Benzofuran anilide histone deacetylase inhibitors
WO2009086012A1 (en) 2007-12-20 2009-07-09 Curis, Inc. Aurora inhibitors containing a zinc binding moiety
EP2100882A1 (en) 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
KR20110022089A (ko) 2008-06-27 2011-03-04 노파르티스 아게 유기 화합물
JP5640006B2 (ja) 2008-07-14 2014-12-10 ギリアード サイエンシーズ， インコーポレイテッド ヒストン脱アセチル化酵素および／またはサイクリン依存性キナーゼの縮合複素環式阻害剤
US8344018B2 (en) 2008-07-14 2013-01-01 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
US8134000B2 (en) 2008-07-14 2012-03-13 Gilead Sciences, Inc. Imidazolyl pyrimidine inhibitor compounds
WO2010014611A1 (en) 2008-07-28 2010-02-04 Gilead Colorado, Inc. Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
WO2010028192A1 (en) 2008-09-03 2010-03-11 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
JP2012502051A (ja) 2008-09-05 2012-01-26 エラン ファーマシューティカルズ，インコーポレイテッド Ｎ−スルホンアミドポリシクル酸ピラゾリル化合物
US8202866B2 (en) 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
UY32158A (es) 2008-10-03 2010-04-30 Astrazeneca Ab Derivados heterociclicos y metodos de uso de los mismos
US20110212943A1 (en) 2008-10-15 2011-09-01 Orchid Research Laboratories Limited Novel bridged cyclic compounds as histone deacetylase inhibitors
JP5779503B2 (ja) 2008-10-29 2015-09-16 イスティチュート スペリオーレ ディ サニータ 酸化ストレスを用いるレトロウイルスレゼルボアの処置
BRPI1007995A2 (pt) 2009-02-23 2019-09-24 Hoffmann La Roche orto-aminoamidas para o tratamento de cãncer.
KR101145345B1 (ko) 2009-04-24 2012-07-09 계명대학교 산학협력단 세포증식 억제제로서 유용한 2-싸이오-4-아미노 피리미딘 유도체 및 그 제조방법
EP2424840B1 (en) 2009-04-27 2014-08-06 Boehringer Ingelheim International GmbH Cxcr3 receptor antagonists
US8362249B2 (en) 2009-04-27 2013-01-29 Boehringer Ingelheim International Gmbh CXCR3 receptor antagonists
WO2010127152A2 (en) 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
JP5713999B2 (ja) 2009-05-15 2015-05-07 コリア リサーチ インスティテュート オブ ケミカル テクノロジー アミド化合物、その製造方法及びそれを含む薬学組成物
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
MX2011013166A (es) 2009-06-08 2012-01-30 Gilead Sciences Inc Compuestos inhibidores de hdac de cicloalquilcarbamatobenzamida-an ilina.
KR20120031170A (ko) 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
CN101648922B (zh) 2009-08-20 2011-08-31 苏州东南药物研发有限责任公司 苯甲酰胺类组蛋白去乙酰酶抑制剂及其用途
WO2012016081A2 (en) 2010-07-30 2012-02-02 The Regents Of The University Of California Method and therapeutic for the treatment and regulation of memory formation
EP2680694B1 (en) 2011-02-28 2019-01-02 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2013011385A2 (en) 2011-07-21 2013-01-24 Lumos, Inc. Pre-cut strips of kinesiology tape
AR092790A1 (es) * 2012-02-01 2015-05-06 Euro Celtique Sa Derivados bencimidazolicos del acido hidroxamico

Similar Documents

Publication Publication Date Title
JP2018150331A5 (enExample)
JP2019038829A5 (enExample)
JP2016040288A5 (enExample)
JP2017533968A5 (enExample)
JP2013514980A5 (enExample)
JP2011526924A5 (enExample)
RU2015143843A (ru) Ингибиторы гистондеацетилазы
JP2013541514A5 (enExample)
JP2020097577A5 (enExample)
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2008505157A5 (enExample)
JP2013540713A5 (enExample)
JP2017535586A5 (enExample)
JP2020535165A5 (enExample)
JP2007508361A5 (enExample)
JP2012504133A5 (enExample)
JP2011507896A5 (enExample)
JP2018537535A5 (enExample)
JP2010504343A5 (enExample)
JP2015523546A5 (enExample)
JP2012502111A5 (enExample)
JP2018538273A5 (enExample)
JP2018525342A5 (enExample)
JP2018529737A5 (enExample)
JP2017521364A5 (enExample)